financetom
Business
financetom
/
Business
/
Verisk Analytics' Q3 Adjusted Earnings, Revenue Increase; 2025 Revenue Outlook Lowered
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Verisk Analytics' Q3 Adjusted Earnings, Revenue Increase; 2025 Revenue Outlook Lowered
Oct 29, 2025 5:02 AM

07:29 AM EDT, 10/29/2025 (MT Newswires) -- Verisk Analytics ( VRSK ) reported Q3 adjusted earnings Wednesday of $1.72 per diluted share, up from $1.67 a year earlier.

Analysts polled by FactSet expected $1.71.

Revenue for the quarter ended Sept. 30 was $768.3 million, compared with $725.3 million a year earlier.

Analysts polled by FactSet expected $776.3 million.

The company reiterated its 2025 adjusted earnings guidance of $6.80 to $7 per diluted share. Analysts polled by FactSet expect $7.

Verisk Analytics ( VRSK ) lowered its 2025 revenue outlook to now be between $3.05 billion and $3.08 billion, from the previous range of $3.09 billion to $3.13 billion. Analysts polled by FactSet expect $3.11 billion.

Shares of Verisk Analytics ( VRSK ) were down more than 7% in recent premarket activity Wednesday.

Price: 214.25, Change: -17.88, Percent Change: -7.70

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Vacasa to be Acquired by Casago; Shares Rise
Vacasa to be Acquired by Casago; Shares Rise
Dec 30, 2024
11:58 AM EST, 12/30/2024 (MT Newswires) -- Vacasa ( VCSA ) and Casago said Monday they have signed a definitive agreement for Casago to purchase all outstanding Vacasa ( VCSA ) shares for $5.02 per share in cash. The per-share purchase price represents a premium of 28% over Vacasa's ( VCSA ) 30-day volume-weighted average price per share and a...
Marinus Pharma Agrees To $151 Million Acquisition By Immedica: Shares Surge Over 40%
Marinus Pharma Agrees To $151 Million Acquisition By Immedica: Shares Surge Over 40%
Dec 30, 2024
Marinus Pharmaceuticals, Inc. ( MRNS ) shares are trading higher on Monday after the company entered into a merger agreement to be acquired by Immedica Pharma AB, implying an enterprise value of approximately $151 million. As per the deal, Immedica will launch a tender offer through a wholly owned subsidiary to acquire all outstanding shares of Marinus common stock at...
Wall Street to close on Jan 9 to honor President Jimmy Carter
Wall Street to close on Jan 9 to honor President Jimmy Carter
Dec 30, 2024
NEW YORK (Reuters) - U.S. stock exchanges will close on Thursday, January 9 in observation of a national day of mourning in honor of former U.S. President Jimmy Carter, who died on Sunday at the age of 100. The New York Stock Exchange and the Nasdaq announced the closures on Monday, a customary gesture to honor deceased presidents. President Joe...
Sierra Metals Adopts Shareholder Rights Plan; Comes After Shareholders Rejected Proposed Takeover Bid by Alpayana
Sierra Metals Adopts Shareholder Rights Plan; Comes After Shareholders Rejected Proposed Takeover Bid by Alpayana
Dec 30, 2024
11:55 AM EST, 12/30/2024 (MT Newswires) -- Sierra Metals ( SMTSF ) was at last look down 3.5% on Monday after saying it has adopted a shareholder rights plan, effective immediately, just days after its shareholders rejected a proposed takeover bid by Alpayana. The rights plan is designed to ensure that the company's shareholders are treated fairly in any takeover...
Copyright 2023-2026 - www.financetom.com All Rights Reserved